Mazefesky Leonard D MD is categorized under Doctors in Monroeville, PA and active since 2011.
Mazefesky Leonard D MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Leonard Mazefesky at the company’s single location by writing to 3824 Northern Pike # 625, Monroeville, Pennsylvania PA 15146 or by phoning (412) 380-2885. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mazefesky Leonard D MD |
| Contact Person: | Leonard Mazefesky |
| Address: | 3824 Northern Pike # 625, Monroeville, Pennsylvania 15146 |
| Phone Number: | (412) 380-2885 |
| Website Address: | premiermedicalassociates.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mazefesky Leonard D MD was started in 2011 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Leonard Mazefesky for inquiries that concern Mazefesky Leonard D MD by calling the company number (412) 380-2885, as your correspondence is most welcome. Additionally, the physical location of the single location of Mazefesky Leonard D MD can be found at the coordinates 40.43839,-79.78038 as well as the street address 3824 Northern Pike # 625 in Monroeville, Pennsylvania 15146.
For its online presence, you may visit Mazefesky Leonard D MD’s website at premiermedicalassociates.com and engage with its social media outlets through on Twitter and on Facebook.